# FDA Inspection 1096121 - AlloSource Inc - July 10, 2019

Source: https://www.keypedia.com/records/fda_inspections/allosource-inc/ebf2b8cd-0401-4080-b219-abc145cd3351
Source feed: FDA_Inspections

> FDA Inspection 1096121 for AlloSource Inc on July 10, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1096121
- Company Name: AlloSource Inc
- Inspection Date: 2019-07-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217455 - 2023-09-07](https://www.keypedia.com/records/fda_inspections/allosource-inc/646b33d3-45d8-4201-8e78-11c804eab293)
- [FDA Inspection 994677 - 2016-12-09](https://www.keypedia.com/records/fda_inspections/allosource-inc/907d6aea-7f4c-494c-a22f-deb703100a76)
- [FDA Inspection 855207 - 2013-11-14](https://www.keypedia.com/records/fda_inspections/allosource-inc/8ce692ce-f8f1-4c99-a969-beaddc24bc6a)
- [FDA Inspection 764470 - 2012-01-10](https://www.keypedia.com/records/fda_inspections/allosource-inc/570f53f5-97e8-4ba8-9400-6cb38b4696e7)
- [FDA Inspection 668744 - 2010-06-25](https://www.keypedia.com/records/fda_inspections/allosource-inc/5d7911e7-559e-4fbd-aa80-9480ec5a1762)

Company: https://www.keypedia.com/companies/allosource-inc/09822ebf-014d-4a18-bd00-dc936ea6a4b8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d